Welcome to LookChem.com Sign In|Join Free

CAS

  • or

264919-83-7

2-(2-(benzyloxy)-1-hydroxyethylidene)Malononitrile is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

264919-83-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 264919-83-7 Structure

  • Basic information

    1. Product Name: 2-(2-(benzyloxy)-1-hydroxyethylidene)Malononitrile
    2. Synonyms: 2-(2-(benzyloxy)-1-hydroxyethylidene)Malononitrile
    3. CAS NO:264919-83-7
    4. Molecular Formula: C12H10N2O2
    5. Molecular Weight: 214.22
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 264919-83-7.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 403.4±45.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.244±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 5.12±0.50(Predicted)
    10. CAS DataBase Reference: 2-(2-(benzyloxy)-1-hydroxyethylidene)Malononitrile(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2-(2-(benzyloxy)-1-hydroxyethylidene)Malononitrile(264919-83-7)
    12. EPA Substance Registry System: 2-(2-(benzyloxy)-1-hydroxyethylidene)Malononitrile(264919-83-7)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 264919-83-7(Hazardous Substances Data)

264919-83-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 264919-83-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,4,9,1 and 9 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 264919-83:
(8*2)+(7*6)+(6*4)+(5*9)+(4*1)+(3*9)+(2*8)+(1*3)=177
177 % 10 = 7
So 264919-83-7 is a valid CAS Registry Number.

264919-83-7Relevant articles and documents

CYCLOBUTYL PYRAZOLOPYRIMIDINE PDE9 INHIBITORS

-

, (2020/07/07)

The present invention is directed to cyclobutyl pyrazolopyrimidine compounds which may be useful as therapeutic agents for the treatment of disorders associated with phosphodiesterase 9 (PDE9). The present invention also relates to the use of such compounds for treating cardiovascular and cerebrovascular diseases, such as hypertension, chronic kidney disease and heart failure, and neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

PYRAZOLOPYRIMIDINE PDE9 INHIBITORS

-

, (2020/07/08)

The present invention is directed to amino and alkyl pyrazolopyrimidine compounds which may be useful as therapeutic agents for the treatment of disorders associated with phosphodiesterase 9 (PDE9). The present invention also relates to the use of such co

PYRAZOLOPYRIMIDINE PDE9 INHIBITORS

-

, (2019/01/04)

The present invention is directed to pyrazolopyrimidine compounds which may be useful as therapeutic agents for the treatment of disorders associated with phosphodiesterase 9 (PDE9). The present invention also relates to the use of such compounds for treating cardiovascular and cerebrovascular diseases, such as hypertension, chronic kidney disease and heart failure, and neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

ATG7 INHIBITORS AND THE USES THEREOF

-

Paragraph 00214, (2018/05/27)

Disclosed are chemical entities which are compounds of formula (I) : or a pharmaceutically acceptable salt thereof, wherein R1, R2, and Ra have the values described herein. Chemical entities according to the disclosure can be useful as inhibitors of ATG7. Further provided are pharmaceutical compositions comprising a chemical entity of the disclosure and methods of using the compositions in the treatment of cancer.

Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction

-

Page column 19-20, (2010/02/05)

There is provided compounds of formula IA and of formula IB, wherein R1, R2, R3, R4and A have meanings given in the description, which are useful in the curative and prophylactic treatment of a medical condition for which inhibition of a cyclic guanosine 3′,5′-monophosphate phosphodiesterase (e.g. cGMP PDE5) is desired.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 264919-83-7